InventisBio Co., Limited (SHA:688382)
China flag China · Delayed Price · Currency is CNY
21.39
+1.42 (7.11%)
At close: Mar 6, 2026

InventisBio Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
37.33168.79185.53--
Revenue Growth (YoY)
-77.89%-9.02%---
Cost of Revenue
-3.92---
Gross Profit
37.33164.87185.53--
Selling, General & Admin
-52.560.8557.9647.71
Research & Development
-384.35442.91461.49315.04
Other Operating Expenses
353.920.090.12-00.05
Operating Expenses
353.92445.82513.18519.44362.8
Operating Income
-316.6-280.95-327.65-519.44-362.8
Interest Expense
--0.66-0.83-1.03-1.19
Interest & Investment Income
-30.0240.4517.3812.76
Currency Exchange Gain (Loss)
-1.561.1819.99-11.33
Other Non Operating Income (Expenses)
-0-0.11-0.27-0.2-0.21
EBT Excluding Unusual Items
-316.6-250.14-287.12-483.31-362.76
Gain (Loss) on Sale of Investments
-1.3---
Gain (Loss) on Sale of Assets
-0.08--0
Other Unusual Items
-8.573.15-0.184.85
Pretax Income
-316.6-240.2-283.98-483.49-357.91
Income Tax Expense
0.24----
Net Income
-316.84-240.2-283.98-483.49-357.91
Net Income to Common
-316.84-240.2-283.98-483.49-357.91
Shares Outstanding (Basic)
576576575509459
Shares Outstanding (Diluted)
576576575509459
Shares Change (YoY)
-0.07%0.26%12.97%10.91%-0.25%
EPS (Basic)
-0.55-0.42-0.49-0.95-0.78
EPS (Diluted)
-0.55-0.42-0.49-0.95-0.78
Free Cash Flow
--249.53-314.04-484.59-278.59
Free Cash Flow Per Share
--0.43-0.55-0.95-0.61
Gross Margin
100.00%97.67%100.00%--
Operating Margin
-848.21%-166.45%-176.61%--
Profit Margin
-848.86%-142.31%-153.06%--
Free Cash Flow Margin
--147.84%-169.27%--
EBITDA
-311.13-275.49-322.31-514.77-360.15
EBITDA Margin
--163.21%-173.73%--
D&A For EBITDA
5.475.475.344.682.64
EBIT
-316.6-280.95-327.65-519.44-362.8
EBIT Margin
--166.45%-176.61%--
Revenue as Reported
-168.79185.53--
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.